Tazarotene
Arazlo, Avage, Duobrii, Fabior, Tazorac (tazarotene) is a small molecule pharmaceutical. Tazarotene was first approved as Tazorac on 1997-06-13. It is used to treat acne vulgaris and psoriasis in the USA. The pharmaceutical is active against retinoic acid receptor beta, retinoic acid receptor alpha, and retinoic acid receptor gamma. In addition, it is known to target chemerin-like receptor 1 and chemerin-like receptor 2.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
skin and connective tissue diseases | D017437 |
Trade Name
FDA
EMA
Arazlo, Avage, Fabior, Tazorac (generic drugs available since 2017-04-03)
CombinationsDuobrii
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Halobetasol propionate
+
Tazarotene
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DUOBRII | Bausch Health Companies | N-209354 RX | 2019-04-25 | 1 products, RLD, RS |
Tazarotene
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TAZORAC | Allergan | N-020600 RX | 1997-06-13 | 2 products, RLD, RS |
AVAGE | Allergan | N-021184 RX | 2002-09-30 | 1 products, RLD, RS |
TAZORAC | Allergan | N-021184 RX | 2000-09-29 | 2 products, RLD, RS |
ARAZLO | Bausch Health Companies | N-211882 RX | 2019-12-18 | 1 products, RLD, RS |
FABIOR | Mayne Group | N-202428 RX | 2012-05-11 | 1 products, RLD, RS |
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
arazlo | New Drug Application | 2019-12-19 |
duobrii | New Drug Application | 2020-01-01 |
fabior | New Drug Application | 2018-06-30 |
tazarotene | ANDA | 2023-05-17 |
tazorac | New Drug Application | 2022-12-15 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
acne vulgaris | EFO_0003894 | D000152 | L70 |
psoriasis | EFO_0000676 | D011565 | L40 |
Agency Specific
FDA
EMA
Expiration | Code | ||
---|---|---|---|
TAZAROTENE, TAZAROTENE, COSETTE | |||
2023-03-13 | CGT |
Patent Expiration
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Tazarotene, Arazlo, Bausch | |||
11311482 | 2038-05-11 | U-2368 | |
Halobetasol Propionate / Tazarotene, Duobrii, Bausch | |||
10251895 | 2036-06-06 | DP | |
10426787 | 2036-06-06 | U-2625 | |
8809307 | 2031-11-02 | DP | |
10478502 | 2031-11-02 | DP | U-2625 |
Tazarotene, Fabior, Mayne Pharma | |||
8808716 | 2030-02-24 | DP | |
10568859 | 2030-02-24 | DP | U-2760 |
10688071 | 2030-02-24 | DP | U-2760 |
HCPCS
No data
Clinical
Clinical Trials
11 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | TAZAROTENE |
INN | tazarotene |
Description | Tazarotene is the ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin. It has a role as a keratolytic drug, a prodrug and a teratogenic agent. It is a retinoid, a thiochromane, a member of pyridines, an acetylenic compound and an ethyl ester. It is functionally related to a tazarotenic acid. |
Classification | Small molecule |
Drug class | arotinoid derivatives |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1 |
Identifiers
PDB | — |
CAS-ID | 118292-40-3 |
RxCUI | 83947 |
ChEMBL ID | CHEMBL1657 |
ChEBI ID | 32184 |
PubChem CID | 5381 |
DrugBank | DB00799 |
UNII ID | 81BDR9Y8PS (ChemIDplus, GSRS) |
Target
Agency Approved
RARB
RARB
RARA
RARA
RARG
RARG
Organism
Homo sapiens
Gene name
RARB
Gene synonyms
HAP, NR1B2
NCBI Gene ID
Protein name
retinoic acid receptor beta
Protein synonyms
HBV-activated protein, hepatitis B virus activated protein, Nuclear receptor subfamily 1 group B member 2, RAR-beta, RAR-epsilon, retinoic acid receptor, beta polypeptide
Uniprot ID
Mouse ortholog
Rarb (218772)
retinoic acid receptor beta (P22605)
Alternate
CMKLR1
CMKLR1
CMKLR2
CMKLR2
Organism
Homo sapiens
Gene name
CMKLR1
Gene synonyms
CHEMR23, DEZ
NCBI Gene ID
Protein name
chemerin-like receptor 1
Protein synonyms
chemerin receptor, chemokine receptor-like 1, Chemokine-like receptor 1, G-protein coupled receptor ChemR23, G-protein coupled receptor DEZ, orphan G-protein coupled receptor, Dez, resolvin E1 receptor
Uniprot ID
Mouse ortholog
Cmklr1 (14747)
chemerin-like receptor 1 (P97468)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,738 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
683 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more